company background image
0NZY logo

Eckert & Ziegler LSE:0NZY Stock Report

Last Price

€46.27

Market Cap

€988.5m

7D

1.6%

1Y

23.8%

Updated

06 Dec, 2024

Data

Company Financials +

0NZY Stock Overview

Manufactures and sells isotope technology components worldwide. More details

0NZY fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Eckert & Ziegler SE Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Eckert & Ziegler
Historical stock prices
Current Share Price€46.27
52 Week High€50.00
52 Week Low€32.72
Beta1.32
11 Month Change17.82%
3 Month Change13.04%
1 Year Change23.80%
33 Year Change-51.75%
5 Year Change1.58%
Change since IPO1,090.99%

Recent News & Updates

Recent updates

Shareholder Returns

0NZYGB Medical EquipmentGB Market
7D1.6%-1.5%0.7%
1Y23.8%-3.9%8.7%

Return vs Industry: 0NZY exceeded the UK Medical Equipment industry which returned -3.9% over the past year.

Return vs Market: 0NZY exceeded the UK Market which returned 8.7% over the past year.

Price Volatility

Is 0NZY's price volatile compared to industry and market?
0NZY volatility
0NZY Average Weekly Movement5.5%
Medical Equipment Industry Average Movement6.3%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.4%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0NZY has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0NZY's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20241,143Harald Hasselmannwww.ezag.com

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services.

Eckert & Ziegler SE Fundamentals Summary

How do Eckert & Ziegler's earnings and revenue compare to its market cap?
0NZY fundamental statistics
Market cap€988.49m
Earnings (TTM)€35.90m
Revenue (TTM)€277.72m

27.5x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0NZY income statement (TTM)
Revenue€277.72m
Cost of Revenue€144.30m
Gross Profit€133.43m
Other Expenses€97.52m
Earnings€35.90m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 27, 2025

Earnings per share (EPS)1.72
Gross Margin48.04%
Net Profit Margin12.93%
Debt/Equity Ratio8.6%

How did 0NZY perform over the long term?

See historical performance and comparison

Dividends

0.1%

Current Dividend Yield

3%

Payout Ratio